ICD-10-CM Billable Code

M11.032

Hydroxyapatite deposition disease, left wrist

Clinical Classification Guidelines

Medical Intelligence & Overview

Hydroxyapatite deposition disease (HADD) is a condition characterized by the accumulation of hydroxyapatite crystals in the soft tissues around joints. When these deposits form in the left wrist, it can lead to pain, swelling, and restricted movement. This condition is part of a broader group of disorders that involve calcium crystal deposits in soft tissues, and it may mimic other joint problems. Recognizing and understanding HADD can help in managing symptoms effectively and improving quality of life.

Causes & Symptoms

Clinical Causes: Unknown exact trigger, but associated with degeneration of tendons and tissues around joints. Repetitive wrist movements or trauma may contribute to crystal deposition. Aging process tends to increase the risk due to tissue degeneration. Metabolic disorders, such as hypercalcemia or hyperparathyroidism, may predispose individuals. Genetic factors might play a role in susceptibility.

Key Symptoms: Localized pain in the wrist, often worsened with movement or pressure. Swelling or a palpable lump around the affected area. Tenderness upon touch. Reduced range of motion in the wrist joint. Potential warmth or redness over the joint due to inflammation.

Diagnostic & Treatment

Diagnosis Path: Diagnosis of hydroxyapatite deposition disease typically involves a combination of clinical evaluation and imaging studies. A healthcare provider will review symptoms, perform a physical examination, and may suggest imaging tests such as X-rays, ultrasound, or MRI. X-rays are particularly useful in identifying radiopaque deposits characteristic of hydroxyapatite crystals. Laboratory tests might be ordered to rule out other conditions, but no specific blood test confirms HADD.

Treatment Protocols: Nonsteroidal anti-inflammatory drugs (NSAIDs) to ease pain and swelling. Application of ice packs to reduce inflammation and soothe discomfort. Physical therapy to maintain joint mobility and strengthen surrounding tissues. Corticosteroid injections for more significant inflammation or persistent symptoms. Activity modification to avoid provoking movements or activities that worsen symptoms. In rare cases, ultrasound-guided aspiration or surgical removal of deposits may be necessary if symptoms are severe or persistent.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M11.032 a billable ICD-10 code?
Yes, M11.032 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M11.032?
Clinical documentation must specify the nature of Hydroxyapatite deposition disease, left wrist and any associated comorbidities for accurate reporting.

Cite this Clinical Reference